PPT-One-month Ticagrelor Monotherapy After PCI in Acute Coronary Syndromes:

Principal Results From the Doubleblind Placebocontrolled ULTIMATEDAPT Trial Gregg W Stone MD Icahn School of Medicine at Mount Sinai on behalf of ShaoLiang Chen and the ULTIMATEDAPT Investigators. Jackevicius BScPhm MSc FCSHP Muhammad Mamdani PharmD MA MPH Jack V Tu MD PhD FRCPC TATINS 3 HYDROXY 3 METHYL glutaryl coenzyme A HMG CoA reductase inhibitors have been shown to significantly re duce morbidity and mortality in pa tients with coronary Carrie Hurst FY1. What we’ll cover in next 30 . mins. …. Definitions. Clinical features and differentiating ACS. ECGs. Management. Complications. Some tips from a 2013 Warwick grad. Case study. What is Acute Coronary Syndrome?. Acute Coronary Syndromes and Diabetes. Chapter 26. Jean-Claude Tardif, Phillipe L. L’Allier,. David H. Fitchett. Acute Coronary Syndrome Checklist. SCREEN. for DM among patients with ACS. USE . anti-platelet therapies, . PLAT. elet Inhibition and patient . O. utcomes trial. Outcomes in patients with a Planned Invasive Strategy. The PLATO trial was funded by AstraZeneca. Invasive. PLATO background. In STEMI and UA/NSTEMI, current guidelines recommend 12 months of aspirin and clopidogrel. د. حسين محمد جمعة . اختصاصي الامراض الباطنة . البورد العربي . كلية طب الموصل . 2010. Key points. The term acute coronary syndrome describes the. Giuseppe . Biondi-Zoccai. , MD. Sapienza University . of. . Rome. , Italy. giuseppe.biondizoccai@uniroma1.it. Learning. . goals. Scope . of. the . problem. Prasugrel. Ticagrelor. Reconciling. the . Associate Professor of Clinical Pharmacy,. SBMU. CLASSIFICATION OF ANTIPLATELET AGENTS. Cyclooxygenase inhibitors. Aspirin. Platelet . P2Y12 receptor . blockers. clopidogrel, . ticlopidine. , . ticagrelor. Coronary Artery Disease. . Includes stable angina and acute coronary syndromes. Ischemia. —. insufficient oxygen supply to meet the requirements of the myocardium. Infarction. —. necrosis or cell death that occurs when severe ischemia is prolonged and decreased perfusion causes irreversible damage to tissue. This handy reference puts essential information at your fingertips! Pocket Reference for the 12-Lead ECG in Acute Coronary Syndromes, 3rd Edition helps you recognize ST segment elevation myocardial infarction (STEMI) by introducing the 5-step approach to 12-lead analysis, making it faster and easier to learn 12-lead interpretation. Clear and concise, this book provides a simple, step-by-step approach along with tables, illustrations, and practice 12-lead ECGs to help you determine the likelihood of the presence of STEMI versus imposters or other causes of ST elevation. Written by two well-known educators, Tim Phalen, a paramedic, and Barbara J. Aehlert, a nurse, this pocket reference is available separately or as a package with its corresponding textbook, The 12-Lead ECG in Acute Coronary Syndromes Text, 3rd Edition.A clear, succinct, pocket-sized approach makes it easy to identify possible ST segment elevation myocardial infarction, determine the likelihood of the top STEMI imposters, and confidently categorize the ECG.Streamlined explanation of STEMI recognition includes an emphasis on STEMI imposters (non-infarct causes of ST elevation).Full-color illustrations clearly depict concepts and skills.Updated approach to ECG interpretation helps you determine STEMI versus other causes of ST elevation.NEW 5-step approach simplifies how to determine non-infarct causes of ST elevation, whether STEMI or STEMI imposter(s).NEW content in Suspecting STEMI chapter includes identifying the J-Point, determining ST elevation, Lead Views, suspecting STEMI, and additional STEMI ECG changes.NEW content in STEMI Imposters chapter includes the top 5 STEMI imposters, ruling out the top STEMI imposters, and a 5-step analysis.NEW content in STEMI Imposters chapter includes the coronary artery anatomy, right ventricular infarction, posterior infarction, and obtaining additional leads.NEW Practice ECGs chapter is devoted to practicing the 5-step approach.NEW Practice ECGs chapter and 23 new 12-lead practice ECGs help you develop skills in 12-lead ECG recognition.NEW Key Point! boxes call attention to essential information. Definition. Acute coronary syndrome (ACS) is a term used to describe a constellation of symptoms resulting from acute myocardial ischemia. ACS includes the diagnosis of unstable angina (UA), non-ST elevation myocardial infarction. CrCl. : creatinine clearance, CTO: chronic total occlusion, DAPT: dual antiplatelet therapy, DOAC: direct oral anticoagulant, . eDAN. : electronic discharge advice notification, GFR: glomerular filtration rate, HF: heart failure, INR: international normalised ratio, LHP: Leeds Health Pathways, LTHT: Leeds Teaching Hospitals NHS Trust, LV: left ventricular, MACE: major adverse cardiovascular event, MI: myocardial infarction, NICE: National Institute for Health and Care Excellence, NSTEMI: non-ST segment elevation myocardial infarction, STEMI: ST segment elevation myocardial infarction, OD: once daily, PAD: peripheral arterial disease, P2Y12: platelet receptor for adenosine diphosphate PCI: percutaneous coronary intervention, PPI: proton pump inhibitor, SPC: summary of product characteristics, TIA: transient ischaemic attack.. Luis Ortega-Paz, MD, PhD. 1. ; Francesco Franchi, MD. 1. ; Fabiana Rollini, MD1, Mattia Galli, MD. 1. ,. 2. Latonya Been, AAS. 1. , Ghussan Ghanem, MD. 1. , . Awss. . Shalhoub. , MD. 1. , Tiffany Ossi, MD. Assist.lec. . . Shaymaa. . Hasan. Abbas. Ischemic Heart Disease. The major goals for the treatment of IHD are to:. • Prevent acute coronary syndromes and death . • Alleviate acute symptoms of myocardial ischemia.